UB Paderborn / Katalog / Suche / in CDI

Breast density in NF1 women: a retrospective study

Familial cancer, 2024-03, Vol.23 (1), p.35-40

2024

Link zum Volltext

Verfügbarkeit prüfen

Stroke‐like events after brain radiotherapy: a large series with long‐term follow‐up

European journal of neurology, 2019-04, Vol.26 (4), p.639-650

2019

Link zum Volltext

Verfügbarkeit prüfen

Prospective observational study on the complications and tolerability of a peripherally inserted central catheter (PICC) in neuro-oncological patients

Supportive care in cancer, 2020-06, Vol.28 (6), p.2789-2795

2020

Link zum Volltext

Verfügbarkeit prüfen

Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival

Journal of neuro-oncology, 2016-01, Vol.126 (2), p.279-288

2016

Link zum Volltext

Verfügbarkeit prüfen

P1359: USING GENE‐MODIFIED AUTOLOGOUS STEM CELLS PROGENY TO REEDUCATE THE TUMOR IMMUNE MICROENVIRONMENT OF SOLID TUMORS (TEM‐GBM STUDY)

HemaSphere, 2022-06, Vol.6 (Suppl), p.1244-1245

2022

Link zum Volltext

Verfügbarkeit prüfen

MC13-0072 Tumor perfusion during bevacizumab and irinotecan in recurrent glioblastoma: A multimodal approach

European journal of cancer (1990), 2013-11, Vol.49, p.S32-S32

2013

Link zum Volltext

Verfügbarkeit prüfen

O8.06 ATRX AND TERT EXPRESSION IN RELAPSING LOW GRADE GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii19-ii19

2014

Link zum Volltext

Verfügbarkeit prüfen

O5.05 FLUORESCEIN-GUIDED REMOVAL OF HIGH-GRADE GLIOMAS WITH A DEDICATED FILTER ON THE SURGICAL MICROSCOPE: PRELIMINARY RESULTS OF THE FLUOGLIO STUDY

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii10-ii10

2014

Link zum Volltext

Verfügbarkeit prüfen

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma

Clinical cancer research, 2015-07, Vol.21 (14), p.3307-3317

2015

Link zum Volltext

Verfügbarkeit prüfen

P02.01 MRI ASSESSMENT OF TUMOR SIZE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii32-ii32

2014

Link zum Volltext

Verfügbarkeit prüfen

P02.03 INCREASED COUNTS OF NK AND NKT CELLS ARE ASSOCIATED WITH PROLONGED SURVIVAL IN PRIMARY GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY IN COMBINATION WITH RADIO- AND CHEMO-THERAPY

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii33-ii33

2014

Link zum Volltext

Verfügbarkeit prüfen

Physical rehabilitation has a positive effect on disability in multiple sclerosis patients

Neurology, 1999-01, Vol.52 (1), p.57

1999

Link zum Volltext

Verfügbarkeit prüfen

P14.01 INTEGRATED GENETIC STUDIES OF NEUROFIBROMATOSIS TYPE 1. A TEN YEAR, ITALIAN EXPERIENCE

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii72-ii72

2014

Link zum Volltext

Verfügbarkeit prüfen

O3.03 THE SPECTRUM OF LATE PAROXYSMAL NEUROLOGICAL SYNDROMES AFTER BRAIN IRRADIATION

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii5-ii5

2014

Link zum Volltext

Verfügbarkeit prüfen

MC13-0033 Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan

European journal of cancer (1990), 2013-11, Vol.49, p.S21-S21

2013

Link zum Volltext

Verfügbarkeit prüfen

CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma : a single-institution study in 50 patients

Journal of neuro-oncology, 2005-09, Vol.74 (3), p.287-293

2005

Link zum Volltext

Verfügbarkeit prüfen

P20.10.B CHARACTERIZATION OF NEW PROGNOSTIC MARKERS IN A COHORT OF ADULT SPINAL EPENDYMOMAS

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii129-ii129

2023

Link zum Volltext

Verfügbarkeit prüfen

P20.03.A PREDICTING THE CLINICAL PHENOTYPE IN NF2 RELATED SCHWANNOMATOSIS PATIENTS USING NEW GENETIC SCORES

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii127-ii127

2023

Link zum Volltext

Verfügbarkeit prüfen

1053P Tumor-restricted delivery of an immune-therapeutic payload by modified macrophages for the treatment of glioblastoma: The TEM-GBM STUDY (NCT03866109)

Annals of oncology, 2023-10, Vol.34, p.S637-S637

2023

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience

Journal of neuro-oncology, 2007-05, Vol.82 (3), p.273-279

2007

Link zum Volltext

Verfügbarkeit prüfen

OS05.6.A Modification of the tumor microenvironment in patients with glioblastoma using autologous, genetically modified, hematopoietic stem cell-based therapy: the TEM-GBM STUDY (NCT03866109)

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii13-ii14

2022

Link zum Volltext

Verfügbarkeit prüfen

284MO Targeting the tumor microenvironment of glioblastoma multiforme using a macrophage-based treatment for the local delivery of immune-therapeutic payload: The TEM-GBM study (NCT03866109)

Annals of oncology, 2022-09, Vol.33, p.S669

2022

Link zum Volltext

Verfügbarkeit prüfen

OS2.3 Relevance of Neurofibromatosistype 1 and schwannomotosis in extramedullary spine tumors

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (Supplement_3), p.iii8-iii8

2019

Link zum Volltext

Verfügbarkeit prüfen

369MO Final results of depatuxizumab mafodotin plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO)

Annals of oncology, 2020-09, Vol.31, p.S399-S400

2020

Link zum Volltext

Verfügbarkeit prüfen

JS04.7.A ANALYSIS OF RNA CLASSIFIES NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS AND IDENTIFIES PATIENTS VULNERABLE TO TARGETED METABOLIC THERAPIES

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii9-ii9

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Breast density in NF1 women: a retrospective study

Stroke‐like events after brain radiotherapy: a large series with long‐term follow‐up

Prospective observational study on the complications and tolerability of a peripherally inserted central catheter (PICC) in neuro-oncological patients

Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival

P1359: USING GENE‐MODIFIED AUTOLOGOUS STEM CELLS PROGENY TO REEDUCATE THE TUMOR IMMUNE MICROENVIRONMENT OF SOLID TUMORS (TEM‐GBM STUDY)

MC13-0072 Tumor perfusion during bevacizumab and irinotecan in recurrent glioblastoma: A multimodal approach

O8.06 ATRX AND TERT EXPRESSION IN RELAPSING LOW GRADE GLIOMA

O5.05 FLUORESCEIN-GUIDED REMOVAL OF HIGH-GRADE GLIOMAS WITH A DEDICATED FILTER ON THE SURGICAL MICROSCOPE: PRELIMINARY RESULTS OF THE FLUOGLIO STUDY

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma

P02.01 MRI ASSESSMENT OF TUMOR SIZE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY

P02.03 INCREASED COUNTS OF NK AND NKT CELLS ARE ASSOCIATED WITH PROLONGED SURVIVAL IN PRIMARY GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY IN COMBINATION WITH RADIO- AND CHEMO-THERAPY

Physical rehabilitation has a positive effect on disability in multiple sclerosis patients

P14.01 INTEGRATED GENETIC STUDIES OF NEUROFIBROMATOSIS TYPE 1. A TEN YEAR, ITALIAN EXPERIENCE

O3.03 THE SPECTRUM OF LATE PAROXYSMAL NEUROLOGICAL SYNDROMES AFTER BRAIN IRRADIATION

MC13-0033 Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan

CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma : a single-institution study in 50 patients

P20.10.B CHARACTERIZATION OF NEW PROGNOSTIC MARKERS IN A COHORT OF ADULT SPINAL EPENDYMOMAS

P20.03.A PREDICTING THE CLINICAL PHENOTYPE IN NF2 RELATED SCHWANNOMATOSIS PATIENTS USING NEW GENETIC SCORES

1053P Tumor-restricted delivery of an immune-therapeutic payload by modified macrophages for the treatment of glioblastoma: The TEM-GBM STUDY (NCT03866109)

Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience

OS05.6.A Modification of the tumor microenvironment in patients with glioblastoma using autologous, genetically modified, hematopoietic stem cell-based therapy: the TEM-GBM STUDY (NCT03866109)

284MO Targeting the tumor microenvironment of glioblastoma multiforme using a macrophage-based treatment for the local delivery of immune-therapeutic payload: The TEM-GBM study (NCT03866109)

OS2.3 Relevance of Neurofibromatosistype 1 and schwannomotosis in extramedullary spine tumors

369MO Final results of depatuxizumab mafodotin plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO)

JS04.7.A ANALYSIS OF RNA CLASSIFIES NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS AND IDENTIFIES PATIENTS VULNERABLE TO TARGETED METABOLIC THERAPIES

Suchergebnisse filtern